Literature DB >> 27699718

Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.

Ming Cao1, Zhu-Qin Gu2,3, Yuan Li1,3, Hui Zhang1,3, Xiao-Juan Dan1, Shan-Shan Cen1, Da-Wei Li1, Piu Chan4,5,6.   

Abstract

Olfactory dysfunction has been reported in Parkinson's disease (PD) patients carrying the LRRK2 G2019S variant in Caucasians but rarely in those with the LRRK2 G2385R variant. In this study, we performed genotyping for the LRRK2 G2385R variant in PD patients recruited from the Movement Disorder Clinic of Xuanwu Hospital in Beijing and in healthy controls randomly selected from the Beijing Longitudinal Study on Aging cohort. The "five-odor olfactory detection array", an olfactory threshold test, was used to assess olfactory function. One hundred and eighty-six participants were enrolled, comprising 43 PD patients without (iPD) and 25 with (LRRK2-PD) the LRRK2 G2385R variant, and 118 healthy controls. Our results showed that the threshold of olfactory identification was significantly worse in PD patients than in controls, but not significantly different between the iPD and LRRK2-PD groups. These findings suggested that although olfactory function in LRRK2-PD patients is impaired, it is similar to that in iPD patients.

Entities:  

Keywords:  LRRK2 G2385R variant; Olfactory dysfunction; Parkinson’s disease

Mesh:

Substances:

Year:  2016        PMID: 27699718      PMCID: PMC5567486          DOI: 10.1007/s12264-016-0070-5

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  29 in total

1.  Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology.

Authors:  S E Daniel; C H Hawkes
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

2.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

3.  Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.

Authors:  Matthew J Farrer; Jeremy T Stone; Chin-Hsien Lin; Justus C Dächsel; Mary M Hulihan; Kristoffer Haugarvoll; Owen A Ross; Ruey-Meei Wu
Journal:  Parkinsonism Relat Disord       Date:  2007-01-10       Impact factor: 4.891

4.  Olfactory dysfunction in LRRK2 G2019S mutation carriers.

Authors:  R Saunders-Pullman; K Stanley; C Wang; M San Luciano; V Shanker; A Hunt; L Severt; D Raymond; L J Ozelius; R B Lipton; S B Bressman
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

5.  [Olfactory testing with "sniffin' sticks" for clinical diagnosis of Parkinson disease].

Authors:  R F Daum; B Sekinger; G Kobal; C J Lang
Journal:  Nervenarzt       Date:  2000-08       Impact factor: 1.214

6.  Selective anosmia in Parkinson's disease?

Authors:  C H Hawkes; B C Shephard
Journal:  Lancet       Date:  1993-02-13       Impact factor: 79.321

Review 7.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

8.  Prevalence of smell loss in Parkinson's disease--a multicenter study.

Authors:  A Haehner; S Boesveldt; H W Berendse; A Mackay-Sim; J Fleischmann; P A Silburn; A N Johnston; G D Mellick; B Herting; H Reichmann; T Hummel
Journal:  Parkinsonism Relat Disord       Date:  2009-01-11       Impact factor: 4.891

9.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

10.  Effects of smoking and smoking cessation on life expectancy in an elderly population in Beijing, China, 1992-2000: an 8-year follow-up study.

Authors:  Xiaobing Tian; Zhe Tang; Jingmei Jiang; Xianghua Fang; Xiaoguang Wu; Wei Han; Shaochen Guan; Hongjun Liu; Lijun Diao; Fei Sun
Journal:  J Epidemiol       Date:  2011-07-09       Impact factor: 3.211

View more
  7 in total

1.  Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease.

Authors:  Chong-Bin Zhong; Qian-Qian Chen; Caroline Haikal; Wen Li; Alexander Svanbergsson; Meike Diepenbroek; Jia-Yi Li
Journal:  Neurosci Bull       Date:  2017-09-18       Impact factor: 5.203

2.  The Association between LRRK2 G2385R and Phenotype of Parkinson's Disease in Asian Population: A Meta-Analysis of Comparative Studies.

Authors:  Wei Di; Zhiyong Zeng; Jingyan Li; Xiaoling Liu; Minzhi Bo; Hua Lv
Journal:  Parkinsons Dis       Date:  2018-07-10

3.  Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease.

Authors:  Shi-Shuang Cui; Rao Fu; Juan-Juan Du; Yi-Qi Lin; Pei Huang; Chao Gao; Hai-Yan Zhou; Sheng-Di Chen
Journal:  BMC Neurosci       Date:  2021-03-26       Impact factor: 3.288

4.  Detection of Motor Dysfunction With Wearable Sensors in Patients With Idiopathic Rapid Eye Movement Disorder.

Authors:  Lin Ma; Shu-Ying Liu; Shan-Shan Cen; Yuan Li; Hui Zhang; Chao Han; Zhu-Qin Gu; Wei Mao; Jing-Hong Ma; Yong-Tao Zhou; Er-He Xu; Piu Chan
Journal:  Front Bioeng Biotechnol       Date:  2021-04-15

5.  Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.

Authors:  Li Shu; Yuan Zhang; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750

Review 6.  Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.

Authors:  Bruce A Chase; Katerina Markopoulou
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

7.  Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson's disease.

Authors:  Haichen Niu; Lingyu Shen; Tongzhou Li; Chao Ren; Sheng Ding; Lei Wang; Zhonghai Zhang; Xiaoyu Liu; Qiang Zhang; Deqin Geng; Xiujuan Wu; Haiying Li
Journal:  Transl Neurodegener       Date:  2018-09-28       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.